VALNEVA SE is a European biotech company developing, manufacturing and commercialising vaccines against infectious diseases with a large unmet medical need. Its affiliate Valneva Austria is a member of BIOTECH AUSTRIA, the association which represents the interests of the growing Austrian biotechnology industry sector.
VAL
Valneva
Company · Austria · EU Transparency Register 116284040570-75
2
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1210 companies & groups on this site, they rank #772 by legislative files engaged, a count of participation, not a measure of influence.
0.5
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2020
in the register since
Declares membership of
- Vaccines Europe
- France Biotech
- Pharmig - Verband der pharmazeutischen Industrie Österreichs (until end 2025)
- ÖVIH - Österreichischer Verband der Impfstoffhersteller
- WKÖ - Austrian Federal Economic Chamber
- Industriellenvereinigung (Vereinigung der Österreichischen Industrie) (until end 2025)
- Biotech Austria
- Signatory of UN Global Compact
- LIF - Läkemedelsindustriföreningens
- LEEM - Les Entreprises du Médicament
- ABPI UK - The Association of the British Pharmaceutical Industry
- Royal Society of Biology (UK)
- and 2 more
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Companies & groups
- Head office
- Lyon, France
- EU office
- Wien
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Valneva in PolicySpeak: request access →
Work at Valneva? so we know who speaks for it.
Their record over time
Valneva filed 2 positions between 11 Jun 2025 and 9 Jun 2026, across 2 of the 665 legislative files tracked here, attaching a full position paper 2 times.
2025 · 1 filed2026 · 1 filed
What they argued
Biotech Austria, an industry association gathering 60+ Austrian life science biotech startups, SMEs, and mid- sized companies, welcomes the EU Commissions proposed EU Biotech Act I (the Act) as a timely initiative that acknowledges biotechnology as a strategic pillar of Europes competitiveness, resilience, and health sovereignty.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Valneva next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 83.
Is this your organization?
Everything on this page comes from Valneva’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.